D

Delcath Systems, Inc

50 employees

Delcath Systems is an interventional oncology company that focuses on the treatment of metastatic liver cancer.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Liver Cancers
Health Care
Intrahepatic cholangiocarcinoma
Ocular Melanoma
Oncology
Hepatocellular carcinoma
Research & Development
Pharmaceutical

Date founded

1987

Funding rounds raised

Total raised

$85M

from 3 investors over 3 rounds

D

Delcath Systems, Inc raised $85M on March 27, 2023

Investors: Logos Global Management, LP and Vivo Capital

D

Delcath Systems, Inc raised $20M on August 9, 2021

Investors: Avenue Capital Group

FAQ